Home Home  >  Investor Relations

Amneal is a global, diversified pharmaceutical company that provides access to high-quality, affordable, and essential medicines.

Press Releases

Stock Information

 8.65 AMRX (NASDAQ) +0.10 +1.17% Volume: 477,837 Pricing delayed 20 minutes 10/04/2024 04:00 PM

In This Section

Results & Reporting

Review the latest results, trading conditions and financial reports.

More

Events & Presentations

View upcoming events and latest presentations

More

Notice of Settlement

Download year list
Date Download
May 18, 2023 Notice of Settlement (opens in new window)
May 11, 2023 Stipulation and Agreement of Compromise and Settlement (opens in new window)

Investor Faq

Get answers to important investor relations questions.

More

Investor Tools

IR Contact

Get answers to your investor relations questions.

More
© Amneal Pharmaceuticals LLC.
All rights reserved.
Powered By Q4 Inc. 5.136.1.1 (opens in new window)
Back to top